News

Jörgen Dahlström joined Mercodia as new CEO as of the 1st of October of 2021. We spoke to him about his background in life science, but more importantly about his desire to drive Mercodia forward. Jör...

We are glad to present another Mercodia customer in our interview series. Please meet InSphero! InSphero is a Swiss-based biotech company that has been perfecting 3D cell-based drug discovery platform...

Welcome to a new Mercodia Webinar where Professor Fredrik Bäckhed from Gothenburg University will discuss the influence of the gut microbiota in type 2 diabetes. We are proud to present Professor Fred...

The Mercodia Glucagon ELISA was chosen for the glucagon measurements in the Restoring Insulin Secretion (RISE) study. Here we present data from the evaluation of our assay, and conclusions drawn from ...

We are happy to present a new Mercodia customer in our interview series. Please meet Dr. Hanne Scholz at Oslo University Hospital. Dr. Hanne Scholz is the Director of the&nbsp...

The microbial ecosystem, microbiota, of the human gut consists of trillions of bacteria and recent data have demonstrated that an altered gut microbiota can be associated with several diseases, rangin...

Today we present Samuel Acreman from OCDEM in Oxford! Samuel Acreman is a PhD student at University of Gothenburg, currently working in Oxford at OCDEM, and has been a Mercodia customer for about seve...

Dr. Jean-Philippe Walhin is Lecturer in Human Physiology at the Department for Health, University of Bath, and has been a customer of Mercodia for around 10 years. “I found Mercodia through a publicat...

For our 30th anniversary, we want to highlight those who are the most important to us; our customers. First out in the series “Meet our customer” is Dr. Susan Burke from Pennington Biomedi...